Apheresis market will expand at a 7.78% CAGR during 2021-2030

A medical process called apheresis involves removing blood from a patient or donor in order to separate the necessary blood components. Blood is separated into its fundamental components, such as red blood cells, plasma, platelets, etc., using a small centrifuge instead of directly collecting it into blood bags. The blood is securely returned to the body with a hydrating solution after collecting the desired product. The market for apheresis in 2021 was USD 1.79 billion, and by 2030 it will be worth USD 3.87 billion, expanding at a 7.78% CAGR during the forecast period. The global apheresis industry is expanding due to rising blood cancer rates among people. Other factors stimulating the growth of the market include the growing use of apheresis procedures in treating illnesses like hematology, cardiovascular, and autoimmune conditions, as well as the rising demand for plasma from the biopharmaceuticals sector.

Market Dynamics


The primary factor stimulating the growth of the market is the rising demand for apheresis to treat disorders like neonatal cardiac lupus, acute disseminated encephalomyelitis, and autoimmune hemolytic anemia. The market is also favorably impacted by rising investments made by major market players in research and development (R&D) activities to introduce an improved blood purification device that treats severe forms of arteriosclerosis obliterans. Additionally, a favorable market outlook is being provided by the increasing use of apheresis to treat diseases like thrombotic thrombocytopenic purpura, autoimmune disease, sepsis, and fulminant hepatic failure. The industry is expanding due to the general public’s growing awareness of the advantages of apheresis. However, the market’s expansion is constrained by a dearth of qualify professionals, blood contamination, and the expense of apheresis procedures.


  • Increasing demand for plasma-derived pharmaceuticals creates enormous prospects for industry expansion.
  • The rising rate of chronic diseases, the rise in surgical procedures, and the rise in accidents and injuries are all driving the market’s expansion.

Market Segmentation

By Product

On the basis of product, the market is segmented into software, apheresis devices, and disposable & reagents. The disposable and reagents segment led the entire market with a significant revenue share in 2020. Additionally, the centrifugal apheresis devices segment will expand rapidly during the forecast period. The centrifugal devices market is expanding due to the benefits of centrifugation over various other methods and its effectiveness in differentiating all blood component types.

By End-User

On the basis of end-user, the market is segmented into hospitals & transfusion centers, blood collection centers & blood component providers. In the year 2020, the blood collection centers and blood component providers segment held the largest revenue share of 67.5%. It is because there are more blood centers, more devices for testing blood components, and more people are conscious of blood collection facilities.

By Application

On the basis of application, the plasmapheresis segment was the biggest market contributor in 2020, with a revenue share of 50.0%. Grifols developed plasmapheresis in 1951 as a method to separate plasma from blood cells. The primary development drivers for the market are the increasing prevalence of blood-related diseases and the rising demand for therapies derived from plasma.

By Technology

The centrifugation process segment led the entire market with significant revenue share and will expand rapidly during the forecast period. Blood components like packed red blood cells (PRBCs) and fresh frozen plasma are frequently prepare using heavy spinning and centrifugation. Since membrane filters are necessary for separating plasma from other cellular components to achieve precise cell separation, membrane separation is predict to grow quickly over the forecast period.

Regional Analysis 

North America is the largest market contributor with a significant revenue share due to the rising rate of blood related conditions like kidney diseases, neurological disorders, and metabolic diseases. In addition, the regional market expansion is also drive by the increasing demand for blood components. Per the American National Red Cross, 6.8 million individuals donate blood annually. Asia Pacific regional market will expand at a rapid rate during the forecast period. It is due to the increase in blood disorders necessitating platelet and plasma transfusions in developing countries like China and India. Asia Pacific market is growing due to the development of the healthcare infrastructure and the rise in the number of healthcare professionals.

Key Players 

  • Cerus Corporation
  • Terumo BCT
  • Asahi Kasei Medical
  • Kawasumi Laboratories
  • Kaneka Corporation
  • Haemonetics Corporation
  • Nikkiso
  • B. Braun Melsungen AG
  • HemaCare Corporation
  • Fresenius Kabi
The market for apheresis in 2021 was USD 1.79 billion, and by 2030 it will be worth USD 3.87 billion. Expanding at a 7.78% CAGR during the forecast period. The market growth is drive by the increasing rate of chronic disorders. Rising surgical procedure frequency, and rising injury or accident cases.

Related Reports:

Battery Management System Market Report – The global battery management system market will witness a robust CAGR of 21.2%. Valued at $6.41 billion in 2021, expected to appreciate and reach $35.79 billion by 2030, confirms Strategic Market Research.